Longer-Term Data Continue to Support Earlier Integration of CAR T-Cell Therapy in R/R Myeloma | OncLive (onclive.com)
Hamza Hashmi, MD, discusses the evolving role and implementation of CAR T-cell therapy in early relapsed/refractory multiple myeloma.
Hazma Hashmi, MD, discusses the evolving role and implementation of CAR T-cell therapy in early relapsed/refractory multiple myeloma. @mskcancercenter.bsky.social #mmsm #hematology #oncology
www.onclive.com/view/longer-...
